ARCHIVES

FDA News: Tentative Approval Given IVAX Paxene; BMS Exclusivity Upheld

This article is from The Cancer Letter archive.

Vol. 24 No. 01 | January 9, 1998

Download PDF Visit The Full Archive

Related Articles

DCPC Board Objects To Cutting Grants Each Award Year

February 17, 1989

Carcinogenicity Test For Cis-Platinum Needed, DCT Says, But Declines To Pay For It

June 16, 1978

CMS will pay oncologists to report adherence to practice guidelines.

November 4, 2005

NCI Chief Operating Officer Lawrence Ray To Retire

April 24, 2009

FDA Moves To Revoke Avastin’s Breast Cancer Accelerated Approval, Genentech Vows To Fight

December 17, 2010

Genasense Added To Chemo Improves Responses in CLL

December 31, 2004